comparemela.com

Latest Breaking News On - Matt gline - Page 1 : comparemela.com

Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2023 Earnings Call Transcript

Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2023 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Frank-torti
Matt-gline
David-risinger
Douglas-tsao
Mayukh-sukhatme
Yaron-werber
Abby-beier
Bristol-myers-squibb
Corinne-johnson
Andy-chen
Louise-chen
Yatin-suneja

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Delaware
United-states
London
City-of
United-kingdom
Miami
Florida
Switzerland
New-york
Stephanie-lee
Sumitomo-pharma
Goldman-sachs

Roivant Sciences (ROIV) Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, $1.5B Share Buyback

Roivant Sciences (ROIV) Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, $1.5B Share Buyback
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Ben-zimmer
Sumitomo-pharma
Matt-gline
Quan-dong-nguyen
Stanford-university-school-of-medicine
Byers-eye-institute
Priovant-therapeutics
Treatment-failure
Stanford-university-school

Roivant Stock Leafrogs Its 50-Day Line On 'Extremely Positive' Eye Drug Test

Roivant Stock Leafrogs Its 50-Day Line On 'Extremely Positive' Eye Drug Test
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Matt-gline
Leerink-risinger
David-risinger
Roivant-sciences
Roivant-chief-executive-matt-gline
Business-daily

vimarsana © 2020. All Rights Reserved.